<DOC>
	<DOCNO>NCT02654626</DOCNO>
	<brief_summary>This randomize , single-blind , placebo-controlled , sequential parallel-group multiple ascend dose ( MAD ) study evaluate safety , tolerability pharmacokinetics KBP 7072 healthy subject . The safety assess dose level progress next high dose .</brief_summary>
	<brief_title>A Multiple Ascending Dose Study KBP-7072 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject Are age 18 55 year ( inclusive ) ; Body mass index ( BMI ) 19 30 kg/m2 inclusive body weight less 50 kg . Clinically significant history gastrointestinal , cardiovascular , musculoskeletal , endocrine , hematologic , psychiatric , renal , hepatic , bronchopulmonary , neurologic , immunologic , lipid metabolism disorder , drug hypersensitivity ; Known suspect malignancy ; Positive blood screen human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C ( HCV ) antibody ; Positive pregnancy test result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>